secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001437749-26-006629
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences updates investor deck with nPulse catheter development, cites 'unprecedented' EU feasibility data
--------------------------------------------------------------------------------

- Updated investor presentation posted on website includes summary financial info and product development update.
- Next-generation nPulse cardiac catheter under development is highlighted.
- Company strengthening focus on EP cardio ablation following 'unprecedented' EU feasibility study outcomes.
- Presentation to be used in meetings with investors and analysts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926006629/0001437749-26-006629-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926006629/plse20260302_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-006629

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer